Previous 10 | Next 10 |
Iovance Biotherapeutics, Inc. (IOVA) Q3 2020 Earnings Conference Call November 05, 2020, 16:30 ET Company Participants Sara Pellegrino - VP, IR & Public Relations Maria Fardis - CEO, President & Director Friedrich Finckenstein - Chief Medical Officer Michael Swartzburg - VP, Finance a...
Iovance Biotherapeutics (IOVA): Q3 GAAP EPS of -$0.40 beats by $0.06.Cash, cash equivalents, and short-term investments of $714.15MPress Release For further details see: Iovance Biotherapeutics EPS beats by $0.06
SAN CARLOS, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL and peripheral-blood lymphocyte, PBL), today reported third quarter...
SAN CARLOS, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will report its third quarter 2020 financial results on Thursday, Nov. 5, 2020. Management will host a...
SAN CARLOS, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that the company plans to present at the following conferences in November: ...
Iovance Biotherapeutics, in an attempt to secure FDA-approval for their biologic, lifileucel, in advanced melanoma, was set back as the FDA requires some more information. This can't come to much of a surprise to investors, as Iovance's TIL therapy carries a complex manufacturing and ...
Are These 3 Penny Stocks On Your Weekly Watch List? Thursday’s brought a whole new round of penny stocks to watch. However, many of these stocks have remained in a bright spotlight all year. One of the biggest factors in penny stocks today is assessing consistency. This i...
5 Penny Stocks To Watch Before The End Of The Week Whether you’re looking at trading or investing in penny stocks , the main goals are simple: avoid losses, make gains, and repeat. It sounds easier said than done but a proven strategy will help that curve flatten a bit. W...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadBig banks will lead off the Q3 earnings season next week with investors likely to see more surprises than normal due to t...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
News, Short Squeeze, Breakout and More Instantly...
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
Iovance Biotherapeutics Inc. Website:
2024-07-29 05:15:07 ET Piper Sandler analyst issues NEUTRAL recommendation for IOVA on July 29, 2024 02:11AM ET. The previous analyst recommendation was Overweight. IOVA was trading at $9.25 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-07-29 05:00:08 ET Joseph Catanzaro from Piper Sandler issued a price target of $10.00 for IOVA on 2024-07-29 02:11:00. The adjusted price target was set to $10.00. At the time of the announcement, IOVA was trading at $9.25. The overall price target consensus is at $...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...